Hypodermic Needles Market: The Self-Administration Trend

1
Hypodermic Needles Market The Self-
Administration Trend
Hypodermic needles are hollow medical equipment
commonly used in conjunction with a syringe. They
are used to extract fluids from the body, to
rapidly deliver liquids, or when the injected
substance cannot be ingested. According to
Inkwood Research, the global hypodermic needles
market is estimated to record a CAGR of
4.60 during the forecasted years of 2023 to
2032. Moreover, hypodermic needles are also
used for research purposes, especially where
sterile conditions are imperative. Chronic
Conditions Hypodermic Needles The Sharp Shift
Toward Self-Administration Hypodermic needles
are primarily utilized by medical
professionals, including dentists, physicians,
phlebotomists, nurses, pharmacists, and
paramedics. However, they can also be used
independently by patients themselves. This
practice is common among
2
individuals diagnosed with type one diabetes,
who may need several insulin injections per
day. According to the International Diabetes
Federation, around 537 million adults between
the age of 20-79 years were living with
diabetes as of 2021. Moreover, this number
is projected to increase to 643 million by 2030
and 783 million by 2045. Since hypodermic needles
are user-friendly and easy to use, their
self-administration by patients is on the
rise. For example, patients with diabetes
need insulin in order to control their blood
sugar levels, which can be self-administered
using hypodermic needles. Furthermore, the
bioavailability and action of drugs,
such as insulin, administered through
intramuscular, subcutaneous, and intravenous
routes are rapid as compared to other routes.
As a result, the increasing prevalence of
diabetes is set to play an essential role in
propelling the demand for hypodermic
needles. How Are Market Players Leveraging the
Self- Administration Trend? Healthcare systems
in leading countries, such as the
United States, have been instrumental in
the drive toward self-administration for
patients with chronic conditions. This is
primarily in response to the mounting pressure
intensified by the lack of funding, staff
shortages, and an aging population. By
shifting the injection of certain therapies
away from the traditional clinical setting
towards the home, hospitals are outsourcing a
lower-risk medical procedure
self-administration. This helps effectively
manage overcrowding within facilities while
encouraging patients to be more involved in their
own treatments. In addition, patients who
self-administer their own treatment are
vested with the responsibility of managing
their medication regimen, thereby alleviating the
pressure on hospitals and medical
practitioners. Aligning with this,
leading manufacturers are
focused on the development of advanced
hypodermic needles, facilitating greater
3

• precision, utility, and easy disposability,
  especially for diabetics as well as other
  home care users. For example
• Nipro (Japan), a leading medical equipment
  manufacturer, develops ultra-sharp
• hypodermic needles that help minimize patient
  discomfort during injection.
• Brauns (Germany) portfolio of needle and
  syringe products entails its Sterican
  hypodermic needles. These needles are
  deployed in injecting insulin, blood
  sampling, and neural therapy, in
  addition to fine dosage and infusion
  pump syringes.
• BD PrecisionGlide hypodermic needles, by
  Becton Dickinson (United States),
• have thin walls, enabling smoother flow and
  easier penetration of the skin. They also
  have a bonded lubricant which facilitates easy
  sliding action.
• At the same time, the use of hypodermic needles
  may carry certain risks, including the
• potential for infection or injury. For instance,
  as per the Centers for Disease Control and
  Prevention, needle stick injuries can be fatal,
  resulting in Hepatitis C, HIV, Hepatitis B,
  and other conditions. As a result, while the
  proper handling and disposal of needles are
  important, adherence to proper sterilization
  procedures is essential, as well.
• Aligning with this, major market players
  are establishing significant efforts toward
  the development of safety needles, which is
  expected to be the prominent type during the
  forecast period (Source Inkwood Research).
• For instance, Pikdare SpA (Italy), a
  subsidiary of MTD Group, received FDA
• approval for its safety needle, DropSafe
  Sicura. Likewise, in January 2022, DALI
  Medical Devices (Israel), a leading creator
  and distributor of drug delivery devices,
  announced the commercial application of its
  SAN-Light passive safety needle. SAN- Light
  is a one-of-a-kind, single-use sterile
  hypodermic safety needle that can be used
  with Luer-lock syringes for intramuscular or
  subcutaneous medication administration. As a
  result, prominent market players are
  leveraging the self-administration trend in
  the global hypodermic needles market through
  strategic product developments.
• FAQs
• What are hypodermic needles made of?

Hypodermic needles are typically made of
stainless steel and polypropylene.
4
What sizes of hypodermic needles are used in
medical applications? Hypodermic needles are
available in various sizes, indicated by the
gauge or diameter of the needle. The size of
hypodermic needles in common medical usage range
from 7 gauge (largest) to 33 (smallest).